Chemclin Diagnostics Co., Ltd. (SHA:688468)
China
· Delayed Price · Currency is CNY 6.99
+0.13 (1.90%)
Apr 30, 2025, 1:45 PM CST
Chemclin Diagnostics Market Cap
Chemclin Diagnostics has a market cap or net worth of 2.71 billion as of April 29, 2025. Its market cap has decreased by -7.55% in one year.
Market Cap
2.71B
Enterprise Value
2.07B
Revenue
436.29M
Ranking
n/a
PE Ratio
21.44
Stock Price
6.99
Market Cap Chart
Since April 9, 2021, Chemclin Diagnostics's market cap has decreased from 10.00B to 2.71B, a decrease of -72.93%. That is a compound annual growth rate of -27.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2025 | 2.71B | 0.15% |
| Dec 31, 2024 | 2.70B | -37.53% |
| Dec 29, 2023 | 4.33B | 13.94% |
| Dec 30, 2022 | 3.80B | -47.15% |
| Dec 31, 2021 | 7.19B | -28.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 315.38B |
| Shenzhen Mindray Bio-Medical Electronics | 261.05B |
| WuXi AppTec | 165.22B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.56B |
| Aier Eye Hospital Group | 120.86B |
| Sichuan Biokin Pharmaceutical | 115.95B |
| Shanghai United Imaging Healthcare | 105.78B |
| Yunnan Baiyao Group Co.,Ltd | 103.01B |